Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

A Mutation in Histone H2B Represents a New Class of Oncogenic Driver.

Bennett RL, Bele A, Small EC, Will CM, Nabet B, Oyer JA, Huang X, Ghosh RP, Grzybowski AT, Yu T, Zhang Q, Riva A, Lele TP, Schatz GC, Kelleher NL, Ruthenburg AJ, Liphardt J, Licht JD.

Cancer Discov. 2019 Jul 23. doi: 10.1158/2159-8290.CD-19-0393. [Epub ahead of print]

PMID:
31337617
2.

UTX/KDM6A Loss Enhances the Malignant Phenotype of Multiple Myeloma and Sensitizes Cells to EZH2 inhibition.

Ezponda T, Dupéré-Richer D, Will CM, Small EC, Varghese N, Patel T, Nabet B, Popovic R, Oyer J, Bulic M, Zheng Y, Huang X, Shah MY, Maji S, Riva A, Occhionorelli M, Tonon G, Kelleher N, Keats J, Licht JD.

Cell Rep. 2017 Oct 17;21(3):628-640. doi: 10.1016/j.celrep.2017.09.078.

3.

MMSET/WHSC1 enhances DNA damage repair leading to an increase in resistance to chemotherapeutic agents.

Shah MY, Martinez-Garcia E, Phillip JM, Chambliss AB, Popovic R, Ezponda T, Small EC, Will C, Phillip MP, Neri P, Bahlis NJ, Wirtz D, Licht JD.

Oncogene. 2016 Nov 10;35(45):5905-5915. doi: 10.1038/onc.2016.116. Epub 2016 Apr 25.

4.

Histone methyltransferase MMSET/NSD2 alters EZH2 binding and reprograms the myeloma epigenome through global and focal changes in H3K36 and H3K27 methylation.

Popovic R, Martinez-Garcia E, Giannopoulou EG, Zhang Q, Zhang Q, Ezponda T, Shah MY, Zheng Y, Will CM, Small EC, Hua Y, Bulic M, Jiang Y, Carrara M, Calogero RA, Kath WL, Kelleher NL, Wang JP, Elemento O, Licht JD.

PLoS Genet. 2014 Sep 4;10(9):e1004566. doi: 10.1371/journal.pgen.1004566. eCollection 2014 Sep.

5.

Single-cell nucleosome mapping reveals the molecular basis of gene expression heterogeneity.

Small EC, Xi L, Wang JP, Widom J, Licht JD.

Proc Natl Acad Sci U S A. 2014 Jun 17;111(24):E2462-71. doi: 10.1073/pnas.1400517111. Epub 2014 Jun 2.

6.

A role for ubiquitin in the spliceosome assembly pathway.

Bellare P, Small EC, Huang X, Wohlschlegel JA, Staley JP, Sontheimer EJ.

Nat Struct Mol Biol. 2008 May;15(5):444-51. doi: 10.1038/nsmb.1401. Epub 2008 Apr 20.

7.

The EF-G-like GTPase Snu114p regulates spliceosome dynamics mediated by Brr2p, a DExD/H box ATPase.

Small EC, Leggett SR, Winans AA, Staley JP.

Mol Cell. 2006 Aug 4;23(3):389-99.

8.

The splicing factor Prp43p, a DEAH box ATPase, functions in ribosome biogenesis.

Leeds NB, Small EC, Hiley SL, Hughes TR, Staley JP.

Mol Cell Biol. 2006 Jan;26(2):513-22.

9.

Evaluation of fluorescent compound interference in 4 fluorescence polarization assays: 2 kinases, 1 protease, and 1 phosphatase.

Turek-Etienne TC, Small EC, Soh SC, Xin TA, Gaitonde PV, Barrabee EB, Hart RF, Bryant RW.

J Biomol Screen. 2003 Apr;8(2):176-84.

PMID:
12844438
10.

Mechanism of Janus kinase 3-catalyzed phosphorylation of a Janus kinase 1 activation loop peptide.

Wang R, Griffin PR, Small EC, Thompson JE.

Arch Biochem Biophys. 2003 Feb 1;410(1):7-15.

PMID:
12559972
11.
12.

Psychosocial-sexual issues.

Small EC.

Obstet Gynecol Clin North Am. 1994 Dec;21(4):773-80. Review.

PMID:
7731647
13.

A view of artificial insemination.

Small EC, Turksoy RN.

Adv Psychosom Med. 1985;12:105-23. No abstract available.

PMID:
4013877
14.

Ovarian carcinoma: management of stress in patients and physicians.

Small EC, Anderson B, Watring WG, Edinger DD Jr, Mitchell GW Jr.

Gynecol Oncol. 1983 Apr;15(2):160-5.

PMID:
6832632
15.

Psychosocial issues in breast disease.

Small EC.

Clin Obstet Gynecol. 1982 Jun;25(2):447-54.

PMID:
7105519
16.

Practical aspects of full-time liaison psychiatry in gynecology.

Small EC, Mitchell GW Jr.

J Reprod Med. 1979 Mar;22(3):151-5.

PMID:
571473
17.

Development of DES-associated clear-cell carcinoma: the importance of regular screening.

Anderson B, Watring WG, Edinger DD Jr, Small EC, Netland AT, Safaii H.

Obstet Gynecol. 1979 Mar;53(3):293-9.

PMID:
424100

Supplemental Content

Loading ...
Support Center